These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 10980826)

  • 1. Homocysteine and coronary risk.
    Seshadri N; Robinson K
    Curr Cardiol Rep; 1999 Jul; 1(2):91-8. PubMed ID: 10980826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Homocysteine and cardiovascular risk].
    Auer J; Berent R; Weber T; Lassnig E; Eber B
    Wien Med Wochenschr; 2001; 151(1-2):25-8. PubMed ID: 11234594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homocysteine: a new cardiac risk factor?
    Chai AU; Abrams J
    Clin Cardiol; 2001 Jan; 24(1):80-4. PubMed ID: 11195611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Homocysteine and coronary artery disease].
    Aro A
    Duodecim; 2003; 119(12):1131-5. PubMed ID: 12868359
    [No Abstract]   [Full Text] [Related]  

  • 5. Endpoints for homocysteine-lowering trials.
    Bostom AG; Garber C
    Lancet; 2000 Feb; 355(9203):511-2. PubMed ID: 10682995
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hyperhomocysteinemia, a risk factor for atherosclerosis: causes and effects].
    Weiss N; Pietrzik K; Keller C
    Dtsch Med Wochenschr; 1999 Sep; 124(38):1107-13. PubMed ID: 10535040
    [No Abstract]   [Full Text] [Related]  

  • 7. Does lowering plasma homocysteine reduce vascular disease risk?
    Miller JW
    Nutr Rev; 2001 Jul; 59(7):242-4. PubMed ID: 11475450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hyperhomocysteinemia and cardiometabolic risk].
    Vannucchi H; Melo SS
    Arq Bras Endocrinol Metabol; 2009 Jul; 53(5):540-9. PubMed ID: 19768245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired homocysteine metabolism and atherothrombotic disease.
    Durand P; Prost M; Loreau N; Lussier-Cacan S; Blache D
    Lab Invest; 2001 May; 81(5):645-72. PubMed ID: 11351038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
    Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial.
    Vermeulen EG; Stehouwer CD; Twisk JW; van den Berg M; de Jong SC; Mackaay AJ; van Campen CM; Visser FC; Jakobs CA; Bulterjis EJ; Rauwerda JA
    Lancet; 2000 Feb; 355(9203):517-22. PubMed ID: 10683000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of homocysteine and coronary artery disease.
    Gauthier GM; Keevil JG; McBride PE
    Clin Cardiol; 2003 Dec; 26(12):563-8. PubMed ID: 14677809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Homocysteine--a risk factor for atherosclerosis].
    Debreceni L
    Orv Hetil; 2001 Jul; 142(27):1439-44. PubMed ID: 11481906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hyperhomocysteinemia in pediatric age and nutritional aspects of folates: an early cardiovascular risk factor].
    Caramia G; Belardinelli R
    Monaldi Arch Chest Dis; 2006 Dec; 66(4):275-85. PubMed ID: 17312847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M;
    Clin Chem Lab Med; 2003 Nov; 41(11):1392-403. PubMed ID: 14656016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements.
    Clarke R; Armitage J
    Semin Thromb Hemost; 2000; 26(3):341-8. PubMed ID: 11011852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analytic Approaches for the Treatment of Hyperhomocysteinemia and Its Impact on Vascular Disease.
    Kang SS; Rosenson RS
    Cardiovasc Drugs Ther; 2018 Apr; 32(2):233-240. PubMed ID: 29679304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homocysteine, vitamin B12 and folate levels in premature coronary artery disease.
    Sadeghian S; Fallahi F; Salarifar M; Davoodi G; Mahmoodian M; Fallah N; Darvish S; Karimi A;
    BMC Cardiovasc Disord; 2006 Sep; 6():38. PubMed ID: 17002799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homocysteine, folate, and cardiovascular disease.
    Ward M
    Int J Vitam Nutr Res; 2001 May; 71(3):173-8. PubMed ID: 11582839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hyperhomocysteinemia. A new coronary risk factor].
    Zacarías-Castillo R; Hernández-Rebollar AE; Zajarias-Rabchinskey A; González-Bárcena D
    Gac Med Mex; 2001; 137(4):335-45. PubMed ID: 11519357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.